The existence of mutations in glutamate receptors was described in prior exome sequencing studies [16], and our data not only confirmed that GRIN2A was mutated in melanoma (5 out of 28 cases) but also showed that GRIN2B was recurrently mutated (Figure 2). The gene discussed is GRIN2A; the disease is melanoma.